FOXP3 and liver cancer: In addition, in patients with many cancer types, like Bladder Cancer (BLCA), Breast Cancer (BRCA), Cervical Cancer (CESC), Colon Cancer (COAD), Esophageal Cancer (ESCA), Head and Neck Cancer (HNSC), Kidney Clear Cell Carcinoma (KIRC), Kidney Papillary Cell Carcinoma (KIRP), Liver Cancer (LIHC), Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Rectal Cancer (READ), Melanoma (SKCM), Stomach Cancer (STAD), Thyroid Cancer (THCA), the LFA-1 expression is positively correlatedwith foxp3 in tumor tissue (Fig. 5E).